• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
COPD and Smoking Status - It Does Matter: Characteristics and Prognosis of COPD According to Smoking Status.慢性阻塞性肺疾病与吸烟状况——至关重要:根据吸烟状况分析慢性阻塞性肺疾病的特征及预后
Chronic Obstr Pulm Dis. 2024 Jan 25;11(1):56-67. doi: 10.15326/jcopdf.2023.0433.
2
Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.丹麦从不吸烟人群中慢性阻塞性肺疾病的特征和结局:一项前瞻性人群研究。
Lancet Respir Med. 2013 Sep;1(7):543-50. doi: 10.1016/S2213-2600(13)70137-1. Epub 2013 Jul 29.
3
Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.哥本哈根城市心脏研究中哮喘、慢性阻塞性肺疾病和哮喘-慢性阻塞性肺疾病重叠患者的长期预后:一项前瞻性基于人群的分析。
Lancet Respir Med. 2016 Jun;4(6):454-62. doi: 10.1016/S2213-2600(16)00098-9. Epub 2016 Apr 6.
4
Characteristics and Prognosis of Never-Smokers and Smokers with Asthma in the Copenhagen General Population Study. A Prospective Cohort Study.从不吸烟者和哮喘吸烟者的特征和预后。哥本哈根普通人群研究。一项前瞻性队列研究。
Am J Respir Crit Care Med. 2015 Jul 15;192(2):172-81. doi: 10.1164/rccm.201502-0302OC.
5
Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.非吸烟慢性阻塞性肺疾病患者与吸烟慢性阻塞性肺疾病患者的临床特征比较:一项回顾性观察研究。
Int J Chron Obstruct Pulmon Dis. 2014;9:57-63. doi: 10.2147/COPD.S52416. Epub 2014 Jan 8.
6
Factors associated with current smoking in COPD patients:A cross-sectional study from the Eastern Black Sea region of Turkey.慢性阻塞性肺疾病(COPD)患者当前吸烟的相关因素:来自土耳其黑海东部地区的一项横断面研究
Tob Induc Dis. 2018 May 22;16:22. doi: 10.18332/tid/90665. eCollection 2018.
7
Association of Smoking Status With Mortality and Hospitalization in Hemodialysis Patients.吸烟状况与血液透析患者死亡率和住院率的关系。
Am J Kidney Dis. 2018 Nov;72(5):673-681. doi: 10.1053/j.ajkd.2018.04.004. Epub 2018 Jun 15.
8
COPD in never smokers: results from the population-based burden of obstructive lung disease study.从不吸烟者中的 COPD:基于人群的阻塞性肺疾病负担研究结果。
Chest. 2011 Apr;139(4):752-763. doi: 10.1378/chest.10-1253. Epub 2010 Sep 30.
9
Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.比较肺功能诊断的慢性阻塞性肺疾病(COPD)和非 COPD 从不吸烟的 I-IV 期非小细胞肺癌患者的临床特征和总生存期。
Int J Chron Obstruct Pulmon Dis. 2019 May 1;14:929-938. doi: 10.2147/COPD.S190244. eCollection 2019.
10
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial.乌美溴铵/维兰特罗在 COPD 现吸烟者和曾吸烟者中的疗效和安全性:EMAX 试验的预先指定分析。
Adv Ther. 2021 Sep;38(9):4815-4835. doi: 10.1007/s12325-021-01855-y. Epub 2021 Aug 4.

引用本文的文献

1
Modelling of biological age in stable and acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病稳定期和急性加重期生物学年龄的建模
BMC Pulm Med. 2025 Aug 19;25(1):398. doi: 10.1186/s12890-025-03841-4.
2
Treatment Patterns and Triple Therapy Utilization in Chinese Patients with Chronic Obstructive Pulmonary Disease: An Analysis of Real-World Data from the Yinzhou Database.中国慢性阻塞性肺疾病患者的治疗模式与三联疗法应用:基于鄞州数据库真实世界数据的分析
Int J Chron Obstruct Pulmon Dis. 2025 Jul 29;20:2659-2670. doi: 10.2147/COPD.S499783. eCollection 2025.
3
Beyond Smoking: Emerging Drivers of COPD and Their Clinical Implications in Low- and Middle-Income Countries: A Narrative Review.超越吸烟:慢性阻塞性肺疾病的新兴驱动因素及其在低收入和中等收入国家的临床意义:一项叙述性综述
J Clin Med. 2025 Jun 30;14(13):4633. doi: 10.3390/jcm14134633.
4
Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015-2019).接受吸入三联疗法时发生急性加重的慢性阻塞性肺疾病患者的特征和结局:美国SIRIUS I队列研究(2015 - 2019年)的结果
Int J Chron Obstruct Pulmon Dis. 2025 Jun 11;20:1851-1864. doi: 10.2147/COPD.S513573. eCollection 2025.
5
Adherence to Exercise Training Within a Multimodal Prehabilitation Program: An Exploratory Study of Influencing Factors.多模式术前康复计划中运动训练的依从性:影响因素的探索性研究
J Clin Med. 2025 May 29;14(11):3813. doi: 10.3390/jcm14113813.
6
Characterizing Tobacco Use Status among a National Cohort of Patients with Chronic Obstructive Pulmonary Disease.描述全国慢性阻塞性肺疾病患者队列中的烟草使用状况。
Ann Am Thorac Soc. 2025 Jun;22(6):944-948. doi: 10.1513/AnnalsATS.202406-659RL.
7
Prognostic impact of chronic obstructive pulmonary disease on short-term and long-term outcomes following coronary artery bypass grafting.慢性阻塞性肺疾病对冠状动脉旁路移植术后短期和长期预后的影响。
Sci Rep. 2025 Jan 13;15(1):1865. doi: 10.1038/s41598-024-83860-z.
8
Long-Term Outcome of Childhood Asthma: Characterizing COPD-A and COPD-C Subtypes in Adulthood.儿童哮喘的长期转归:成年期慢性阻塞性肺疾病A和慢性阻塞性肺疾病C亚型的特征分析
J Asthma Allergy. 2024 Dec 14;17:1291-1300. doi: 10.2147/JAA.S474417. eCollection 2024.
9
The impact of body mass index on mortality in COPD: an updated dose-response meta-analysis.体重指数对 COPD 死亡率的影响:一项更新的剂量-反应荟萃分析。
Eur Respir Rev. 2024 Nov 27;33(174). doi: 10.1183/16000617.0261-2023. Print 2024 Oct.
10
Unveiling the Long-Term Lung Consequences of Smoking and Tobacco Consumption: A Narrative Review.揭示吸烟和烟草消费对肺部的长期影响:一篇叙述性综述。
Cureus. 2024 Aug 8;16(8):e66415. doi: 10.7759/cureus.66415. eCollection 2024 Aug.

本文引用的文献

1
Effects of different interventions on smoking cessation in chronic obstructive pulmonary disease patients: A systematic review and network meta-analysis.不同干预措施对慢性阻塞性肺疾病患者戒烟效果的影响:系统评价和网络荟萃分析。
Int J Nurs Stud. 2022 Dec;136:104362. doi: 10.1016/j.ijnurstu.2022.104362. Epub 2022 Sep 14.
2
Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment.从不吸烟者的慢性阻塞性肺疾病:危险因素、发病机制及对预防和治疗的意义。
Lancet Respir Med. 2022 May;10(5):497-511. doi: 10.1016/S2213-2600(21)00506-3. Epub 2022 Apr 12.
3
Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients.慢阻肺 GOLD 分级 B 患者中 1 次中度加重的疾病进程及影响
Int J Chron Obstruct Pulmon Dis. 2022 Mar 16;17:569-578. doi: 10.2147/COPD.S344669. eCollection 2022.
4
Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action.过去半个世纪全球吸烟流行情况的演变:加强政策行动的证据基础
Tob Control. 2022 Mar;31(2):129-137. doi: 10.1136/tobaccocontrol-2021-056535.
5
Risk factors for chronic obstructive pulmonary disease in never-smokers: A systematic review.从不吸烟者慢性阻塞性肺疾病的危险因素:系统评价。
Clin Respir J. 2022 Apr;16(4):261-275. doi: 10.1111/crj.13479. Epub 2022 Feb 10.
6
Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT.COPD 患者中体质量指数与死亡率和加重风险的关系:TIOSPIR 和 UPLIFT 研究
Ann Am Thorac Soc. 2022 Feb;19(2):204-213. doi: 10.1513/AnnalsATS.202006-722OC.
7
Withdrawal of Inhaled Corticosteroids in Patients with COPD - A Prospective Observational Study.COPD 患者吸入性皮质类固醇的撤药 - 一项前瞻性观察研究。
Int J Chron Obstruct Pulmon Dis. 2021 Mar 26;16:807-815. doi: 10.2147/COPD.S294217. eCollection 2021.
8
Effects of Tobacco Smoking on Cardiovascular Disease.吸烟对心血管疾病的影响。
Circ J. 2019 Sep 25;83(10):1980-1985. doi: 10.1253/circj.CJ-19-0323. Epub 2019 Aug 29.
9
Air pollution, lung function and COPD: results from the population-based UK Biobank study.空气污染、肺功能与 COPD:基于人群的英国生物库研究结果。
Eur Respir J. 2019 Jul 25;54(1). doi: 10.1183/13993003.02140-2018. Print 2019 Jul.
10
Chronic Obstructive Pulmonary Disease and Smoking Status - United States, 2017.慢性阻塞性肺疾病与吸烟状况-美国,2017 年。
MMWR Morb Mortal Wkly Rep. 2019 Jun 21;68(24):533-538. doi: 10.15585/mmwr.mm6824a1.

慢性阻塞性肺疾病与吸烟状况——至关重要:根据吸烟状况分析慢性阻塞性肺疾病的特征及预后

COPD and Smoking Status - It Does Matter: Characteristics and Prognosis of COPD According to Smoking Status.

作者信息

Nielsen Anne O, Lange Peter, Hilberg Ole, Farver-Vestergaard Ingeborg, Ibsen Rikke, Løkke Anders

机构信息

Department of Pulmonary Medicine, North Zealand Hospital Hillerød, Copenhagen, Denmark.

Department of Pulmonary Medicine, Herlev/Gentofte Hospital, Copenhagen, Denmark.

出版信息

Chronic Obstr Pulm Dis. 2024 Jan 25;11(1):56-67. doi: 10.15326/jcopdf.2023.0433.

DOI:10.15326/jcopdf.2023.0433
PMID:37828634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10913926/
Abstract

BACKGROUND

Chronic obstructive pulmonary disease is a chronic, often progressive disease, which in most patients is caused by tobacco smoking. Our study focuses on differences in COPD-related outcomes between never smokers, former smokers, and current smokers.

METHODS

A nationwide, population-based cohort study utilizing Danish health registries. Clinical and socioeconomic variables including smoking status, comorbidities, and dyspnea were obtained. Poisson and Cox Regression were used to calculate the impact of these clinical parameters on the risk of moderate and severe exacerbations and mortality during 12 months of follow-up.

RESULTS

A total of 49,826 patients ≥40 years of age, with a hospital diagnosis of COPD in 2008-2017, were identified (mean age 69.2 years, 52% females). A total of 2127 (4%) were never smokers, 29,854 (60%) were former smokers and 17,845 (36%) current smokers. Compared to former and current smokers, never smokers reported a lower modified Medical Research Council score and had a milder COPD stage according to the Global Initiative for Chronic Obstructive Lung Disease classification. During follow-up, never smokers had a significantly lower risk of severe exacerbations (hazard ratio 0.87, 95% confidence interval [CI] 0.78-0.97) and a lower rate of death (mortality ratio 0.75, 95% CI 0.70-0.81) compared to patients with a smoking history.

DISCUSSION

Our nationwide study showed that COPD in never smokers is characterized by a lower level of dyspnea, milder lung function impairment, and a lower risk of exacerbations and death. At the same time, we found active smokers to have the highest risk. These findings highlight the need for campaigns to prevent smoking and may help general practitioners as well as other health care professionals to motivate patients with COPD to stop smoking.

摘要

背景

慢性阻塞性肺疾病是一种慢性且通常呈进行性发展的疾病,在大多数患者中由吸烟引起。我们的研究聚焦于从不吸烟者、既往吸烟者和当前吸烟者之间慢性阻塞性肺疾病相关结局的差异。

方法

一项利用丹麦健康登记系统的全国性基于人群的队列研究。获取了包括吸烟状况、合并症和呼吸困难在内的临床及社会经济变量。采用泊松回归和Cox回归计算这些临床参数对随访12个月期间中度和重度加重风险及死亡率的影响。

结果

共确定了49826例年龄≥40岁且在2008 - 2017年有医院诊断为慢性阻塞性肺疾病的患者(平均年龄69.2岁,52%为女性)。其中2127例(4%)从不吸烟,29854例(60%)为既往吸烟者,17845例(36%)为当前吸烟者。与既往吸烟者和当前吸烟者相比,从不吸烟者报告的改良医学研究委员会评分较低,且根据慢性阻塞性肺疾病全球倡议分类其慢性阻塞性肺疾病阶段较轻。在随访期间,与有吸烟史的患者相比,从不吸烟者发生严重加重的风险显著更低(风险比0.87,95%置信区间[CI] 0.78 - 0.97),死亡率也更低(死亡率比0.74,95% CI 0.70 - 0.81)。

讨论

我们的全国性研究表明,从不吸烟者的慢性阻塞性肺疾病具有呼吸困难程度较低、肺功能损害较轻、加重和死亡风险较低的特点。同时,我们发现当前吸烟者风险最高。这些发现凸显了开展戒烟宣传活动的必要性,并可能有助于全科医生以及其他医护人员激励慢性阻塞性肺疾病患者戒烟。